EXHIBIT 10.40 CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. April 5, 2004 Qiagen NV c/o Qiagen...Co-Exclusive License and Supply Agreement • August 13th, 2004 • Epoch Biosciences Inc • In vitro & in vivo diagnostic substances • West Coast
EXECUTION COPY CO-EXCLUSIVE LICENSE AND SUPPLY AGREEMENT THIS CO-EXCLUSIVE LICENSE AND SUPPLY AGREEMENT (this "Agreement") is made and entered into as of the 4th day of November 2002 (the "Effective Date"), between EPOCH BIOSCIENCES, INC., a Delaware...Co-Exclusive License and Supply Agreement • March 31st, 2003 • Epoch Biosciences Inc • In vitro & in vivo diagnostic substances • Delaware
